Get the Stockscreener App
2.925
5.65%
-0.175
After Hours:
2.91
-0.015
-0.51%
Eupraxia Pharmaceuticals Inc Stock (EPRX) Forecast
The Eupraxia Pharmaceuticals Inc (EPRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.4006, representing a -17.93% decrease from the current price of $2.925. The highest analyst price target is $2.6372, and the lowest is $2.164.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EPRX Price Target
Average 2.1346
(-27.02% Downside)
Is Eupraxia Pharmaceuticals Inc (EPRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 26.91 | Buy |
| STOCH(9,6) | 13.02 | Buy |
| STOCHRSI(14) | 0.04 | Buy |
| MACD(12,26) | -0.1665 | Sell |
| ADX(14) | 30.97 | Sell |
| William %R | -99.62 | Buy |
| CCI(14) | -83.32 | Neutral |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.3175
Sell
|
3.3202
Sell
|
| MA20 |
3.6873
Sell
|
3.5029
Sell
|
| MA50 |
3.5359
Sell
|
3.5176
Sell
|
| MA100 |
3.3536
Sell
|
3.3554
Sell
|
| MA200 |
2.9892
Sell
|
3.1001
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, EPRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on EPRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 26.91 indicates that EPRX is oversold. This indicates that EPRX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 13.02 indicates that EPRX is oversold. This indicates that EPRX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0.04 indicates that EPRX is oversold. This suggests that EPRX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 30.97 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -83.32 indicates that EPRX is still oversold but not to an extreme extent.
Long-term EPRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Eupraxia Pharmaceuticals Inc financial reports and earnings history, Eupraxia Pharmaceuticals Inc (EPRX) stock could reach $0.6645 by 2030, $3.8729 by 2040 and $8.0725 by 2050. See the projected annual prices until 2050 of the Eupraxia Pharmaceuticals Inc stock below:
- Eupraxia Pharmaceuticals Inc (EPRX) is expected to reach an average price of $1.856 in 2035, with a high prediction of $1.792 and a low estimate of $1.802. This indicates an $-36.55% rise from the last recorded price of $2.925.
- Eupraxia Pharmaceuticals Inc (EPRX) stock is projected to chart a bullish course in 2040, with an average price target of $3.962, representing an $35.45% surge from its current level. The forecast ranges from a conservative $3.8829 to a sky-high $3.8729.
- Our analysts predict Eupraxia Pharmaceuticals Inc (EPRX) to jump 107.94% by 2045, soaring from $5.9638 to an average price of $6.0823, potentially reaching $5.9665. While $5.9638 is the low estimate, the potential upside is significant.
- Eupraxia Pharmaceuticals Inc (EPRX) stock is expected to climb by 2050, reaching an average of $8.0297, a $174.52% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8.0725 and $8.0447, respectively, highlighting the market's uncertainty.
Eupraxia Pharmaceuticals Inc Stock (EPRX) Year by Year Forecast
Eupraxia Pharmaceuticals Inc Stock (EPRX) Price Forecast for 2025
Eupraxia Pharmaceuticals Inc Stock (EPRX) is expected to reach an average price of $2.2555 in 2025, with a high prediction of $2.7579 and a low estimate of $1.7532. This indicates an -22.89% fall from the last recorded price of $2.925.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $2.2345 | $2.164 | $2.6372 | -23.61% |
| June, 2025 | $2.2962 | $1.9954 | $2.5969 | -21.50% |
| July, 2025 | $2.2559 | $1.9551 | $2.5566 | -22.88% |
| August, 2025 | $2.1781 | $1.9147 | $2.5164 | -25.54% |
| September, 2025 | $2.196 | $1.8743 | $2.4761 | -24.92% |
| October, 2025 | $2.1558 | $1.8339 | $2.4359 | -26.30% |
| November, 2025 | $1.9935 | $1.7935 | $2.1828 | -31.84% |
| December, 2025 | $1.9532 | $1.7532 | $2.3956 | -33.22% |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Price Forecast for 2026
The predicted value for Eupraxia Pharmaceuticals Inc (EPRX) in 2026 is set at an average of $1.8524. Estimates vary from a peak of $2.3553 to a trough of $1.3494, indicating an -36.67% surge from the present price of $2.925.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.951 | $1.8805 | $2.3553 | -33.30% |
| February, 2026 | $2.0139 | $1.7128 | $2.3151 | -31.15% |
| March, 2026 | $1.9372 | $1.6724 | $2.2748 | -33.77% |
| April, 2026 | $1.8971 | $1.632 | $2.2346 | -35.14% |
| May, 2026 | $1.9142 | $1.5917 | $2.1943 | -34.56% |
| June, 2026 | $1.7513 | $1.5513 | $1.942 | -40.13% |
| July, 2026 | $1.7109 | $1.5109 | $2.154 | -41.51% |
| August, 2026 | $1.708 | $1.6375 | $2.1138 | -41.61% |
| September, 2026 | $1.6675 | $1.4705 | $2.0735 | -42.99% |
| October, 2026 | $1.7317 | $1.4301 | $2.0333 | -40.80% |
| November, 2026 | $1.6563 | $1.3898 | $1.993 | -43.38% |
| December, 2026 | $1.6161 | $1.3494 | $1.9528 | -44.75% |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Eupraxia Pharmaceuticals Inc (EPRX) is $1.429, with a high forecast of $1.9125 and a low forecast of $0.9456. This indicates an -51.14% decrease from the last price of $2.925.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.6324 | $1.309 | $1.9125 | -44.19% |
| February, 2027 | $1.4686 | $1.2686 | $1.661 | -49.79% |
| March, 2027 | $1.4282 | $1.2282 | $1.8722 | -51.17% |
| April, 2027 | $1.4245 | $1.354 | $1.832 | -51.30% |
| May, 2027 | $1.4898 | $1.1879 | $1.7917 | -49.07% |
| June, 2027 | $1.4495 | $1.1475 | $1.7515 | -50.45% |
| July, 2027 | $1.3753 | $1.1071 | $1.7112 | -52.98% |
| August, 2027 | $1.3908 | $1.0667 | $1.6709 | -52.45% |
| September, 2027 | $1.3506 | $1.0263 | $1.6307 | -53.83% |
| October, 2027 | $1.186 | $0.986 | $1.38 | -59.45% |
| November, 2027 | $1.1815 | $1.111 | $1.5904 | -59.61% |
| December, 2027 | $1.141 | $0.9456 | $1.5502 | -60.99% |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Price Forecast for 2028
In 2028, Eupraxia Pharmaceuticals Inc (EPRX) is projected to reach an average price of $1.0057, with a high projection of $1.5099 and a low estimate of $0.5014. This indicates an -65.62% fall from the last price of $2.925.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.2076 | $0.9052 | $1.5099 | -58.72% |
| February, 2028 | $1.1345 | $0.8648 | $1.4696 | -61.21% |
| March, 2028 | $1.0943 | $0.8244 | $1.4294 | -62.59% |
| April, 2028 | $1.109 | $0.7841 | $1.3891 | -62.08% |
| May, 2028 | $1.0688 | $0.7437 | $1.3489 | -63.46% |
| June, 2028 | $0.9033 | $0.7033 | $1.0991 | -69.12% |
| July, 2028 | $0.898 | $0.8275 | $1.3086 | -69.30% |
| August, 2028 | $0.8575 | $0.6629 | $1.2684 | -70.68% |
| September, 2028 | $0.9253 | $0.6225 | $1.2281 | -68.37% |
| October, 2028 | $0.8535 | $0.5822 | $1.1878 | -70.82% |
| November, 2028 | $0.8134 | $0.5418 | $1.1476 | -72.19% |
| December, 2028 | $0.8272 | $0.5014 | $1.1073 | -71.72% |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Price Forecast for 2029
The 2029 price forecast for Eupraxia Pharmaceuticals Inc Stock (EPRX) is $0.5823 on average, with a high prediction of $1.0671 and a low estimate of $0.0976. This represents an -80.09% decrease from the previous price of $2.925.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.787 | $0.461 | $1.0671 | -73.10% |
| February, 2029 | $0.6206 | $0.4206 | $0.8181 | -78.78% |
| March, 2029 | $0.6145 | $0.544 | $1.0268 | -78.99% |
| April, 2029 | $0.6834 | $0.3803 | $0.9865 | -76.64% |
| May, 2029 | $0.6431 | $0.3399 | $0.9463 | -78.01% |
| June, 2029 | $0.5725 | $0.2995 | $0.906 | -80.43% |
| July, 2029 | $0.5857 | $0.2591 | $0.8658 | -79.98% |
| August, 2029 | $0.5454 | $0.2188 | $0.8255 | -81.35% |
| September, 2029 | $0.3784 | $0.1784 | $0.5773 | -87.06% |
| October, 2029 | $0.338 | $0.138 | $0.7852 | -88.44% |
| November, 2029 | $0.331 | $0.2605 | $0.745 | -88.68% |
| December, 2029 | $0.4012 | $0.0976 | $0.7047 | -86.28% |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Price Forecast for 2030
Eupraxia Pharmaceuticals Inc Stock (EPRX) is expected to reach an average price of $0.3327 in 2030, with a high forecast of $0.6645 and a low forecast of $0.000876. This signifies an -88.63% decrease from the last price of $2.925.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.3609 | $0.0572 | $0.6645 | -87.66% |
| February, 2030 | $0.2916 | $0.0169 | $0.6242 | -90.03% |
| March, 2030 | $0.3039 | $0.0235 | $0.584 | -89.61% |
| April, 2030 | $0.1361 | $0.0639 | $0.3364 | -95.35% |
| May, 2030 | $0.0957 | $0.058 | $0.5437 | -96.73% |
| June, 2030 | $0.088 | $0.0175 | $0.5034 | -96.99% |
| July, 2030 | $0.0475 | $0.023 | $0.4632 | -98.38% |
| August, 2030 | $0.2119 | $0.000876 | $0.4229 | -92.76% |
| September, 2030 | $0.0507 | $0.00266 | $0.3827 | -98.27% |
| October, 2030 | $0.0106 | $0.00118 | $0.3424 | -99.64% |
| November, 2030 | $0.022 | $0.0412 | $0.3021 | -99.25% |
| December, 2030 | $0.1466 | $0.0812 | $0.0712 | -94.99% |
10.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):